Bausch Health Companies Inc. (BHC) News
Filter BHC News Items
BHC News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
BHC News Highlights
-
404 Page not found Error: Page not found
The requested URL was not found on this server.
-
404 Page not found Error: Page not found
The requested URL was not found on this server.
-
404 Page not found Error: Page not found
The requested URL was not found on this server.
Latest BHC News From Around the Web
Below are the latest news stories about BAUSCH HEALTH COMPANIES INC that investors may wish to consider to help them evaluate BHC as an investment opportunity.
Is Bausch + Lomb (BLCO) the Best Medical Stock to Buy Under $20?We recently compiled a list of the Best Medical Stocks To Buy Under $20. In this article, we are going to take a look at where Bausch + Lomb Corporation (NYSE:BLCO) stands against the other best medical stocks under $20. The medical industry plays a crucial role in ensuring the health and safety of populations. […] |
Is Bausch Health Companies (BHC) the Best Medical Stock to Buy Under $20?We recently compiled a list of the Best Medical Stocks To Buy Under $20. In this article, we are going to take a look at where Bausch Health Companies Inc. (NYSE:BHC) stands against the other best medical stocks under $20. The medical industry plays a crucial role in ensuring the health and safety of populations. […] |
Here's Why Bausch Health (BHC) is a Strong Momentum StockWhether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service. |
Is Bausch Health Companies (BHC) Among Billionaire Paul Singer’s Top Long-Term Stock Picks?We recently published a list of Billionaire Paul Singer’s Top 12 Long-Term Stock Picks. In this article, we are going to take a look at where Bausch Health Companies Inc. (NYSE:BHC) stands against other Billionaire Paul Singer’s long-term stock picks. The world’s “most feared investor,” Paul Singer, needs no introduction. He has built a reputation […] |
Contact lens maker Bausch + Lomb says it is exploring saleBausch + Lomb also said its statement was in response to a request from the Canadian Investment Regulatory Organization (CIRO) after a series of media reports on its likely sale triggered volatility in its shares. A month prior, the FT had reported that the company had hired an investment bank to explore a sale, sending its shares surging more than 37% until the newspaper's report on Blackstone's cooling interest earlier this week led to a sharp fall in its stock price. A sale could end a long process by parent Bausch Health to offload its stake in the eyecare company. |
Bausch Health Responds to Rumors of a Potential Sale of Bausch + LombBausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) (the "Company" or "Bausch Health"), a global, diversified pharmaceutical company enriching lives through a relentless drive to deliver better health outcomes, issued the following statement in response ... |
Eye health company Bausch + Lomb’s affiliate acquires Elios VisionThe acquisition strengthens Bausch + Lomb's existing portfolio of surgical and pharmaceutical glaucoma treatments. |
TSX Closer: The Market Surges as the Bank of Canada Makes Its Jumbo Cut, Further Cuts PredictedCanada's largest stock market, the Toronto Stock Exchange closed higher on Wednesday, climbing after |
TSX up 105 Points at Midday, With Info Tech, Energy, Higher; Healthcare The Biggest DeclinerThe Toronto Stock Exchange is up 105 points with info tech (+1.2%) and energy (+0.6%), the sole gain |
Bausch + Lomb down after report that Blackstone could back away from takeover bidInvesting.com --Bausch + Lomb Corp (NYSE:BLCO) shares tumbled more than 12% on Wednesday in New York Stock Exchange after report that Blackstone (NYSE:BX) could back away from a joint bid to acquire the eyecare company, raising doubts about one of the largest healthcare buyouts of the year. |